tiprankstipranks
Ideaya Biosciences reports Q4 EPS ($1.49), consensus (62c)
PremiumThe FlyIdeaya Biosciences reports Q4 EPS ($1.49), consensus (62c)
9d ago
IDEAYA Biosciences Appoints New Chief Financial Officer
Premium
Company Announcements
IDEAYA Biosciences Appoints New Chief Financial Officer
12d ago
Ideaya enters license agreement for SHR-4849 with Jiangsu Hengrui
Premium
The Fly
Ideaya enters license agreement for SHR-4849 with Jiangsu Hengrui
2M ago
Ideaya Biosciences nominates IDE892 as development candidate
PremiumThe FlyIdeaya Biosciences nominates IDE892 as development candidate
3M ago
Ideaya Biosciences initiated with an Overweight at Stephens
Premium
The Fly
Ideaya Biosciences initiated with an Overweight at Stephens
3M ago
Ideaya Biosciences appoints Stu Dorman as chief commercial officer
Premium
The Fly
Ideaya Biosciences appoints Stu Dorman as chief commercial officer
3M ago
Ideaya Biosciences downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyIdeaya Biosciences downgraded to Market Perform from Outperform at Leerink
4M ago
IDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
Premium
Company Announcements
IDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
4M ago
Ideaya Biosciences reports Q3 EPS (60c), consensus (63c)
Premium
The Fly
Ideaya Biosciences reports Q3 EPS (60c), consensus (63c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100